T0	PROCESS 0 1	dangerous manifestation
T0	PROCESS 0 1	lyme disease
T0	PROCESS 0 1	early antimicrobial treatment
T0	PROCESS 0 1	persistent form
T0	PROCESS 0 1	mechanism underlying chronic lnb
T0	PROCESS 0 1	late manifestation
T0	PROCESS 0 1	incomplete resolution
T0	PROCESS 0 1	persistent borrelia infection
T0	PROCESS 0 1	prolonged antimicrobial treatment
T0	PROCESS 0 1	controversial clinical efficacy
T0	PROCESS 0 1	recent evidence
T0	PROCESS 0 1	antibiotic resistance
T0	PROCESS 0 1	biofilm-like aggregate
T0	PROCESS 0 1	borrelia spp
T0	PROCESS 0 1	environmental condition
T0	PROCESS 0 1	fda-approved drug
T0	PROCESS 0 1	excellent antipersister activity
T0	PROCESS 0 1	monotherapy regimen
T0	PROCESS 0 1	poor effectiveness
T0	PROCESS 0 1	careful consideration
T0	PROCESS 0 1	clinical management
T0	PROCESS 0 1	long-term complication
